Fig. 2From: Radiation field size and dose determine oncologic outcome in esophageal cancerOverall survival of patients who underwent definitive chemoradiotherapy (Def-CRT) with different radiotherapy doses. Overall median survival in patients who received 50 Gy was 90 months (95 % CI 21–159). Median survival was not reached in patients who received >50 Gy. Five-year survival rates were 50 % (95 % CI 42–58) and 91 % (95 % CI 82–100), respectively (p = 0.013)Back to article page